创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: PBMC-T Platform

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-22 15:40
  • Views:

(Summary description)The PBMC-T platform from InnoModels Biotechnology is an innovative technology leading the way in biomedical research, designed to deliver highly efficient T-cell products and provide excellent tools and resources to support researchers in the fields of immunotherapy, cancer research, and infectious diseases, among others

InnoModels Biotechnology: PBMC-T Platform

(Summary description)The PBMC-T platform from InnoModels Biotechnology is an innovative technology leading the way in biomedical research, designed to deliver highly efficient T-cell products and provide excellent tools and resources to support researchers in the fields of immunotherapy, cancer research, and infectious diseases, among others

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-22 15:40
  • Views:
Information

The PBMC-T platform from InnoModels Biotechnology is an innovative technology leading the way in biomedical research, designed to deliver highly efficient T-cell products and provide excellent tools and resources to support researchers in the fields of immunotherapy, cancer research, and infectious diseases, among others.
1. Efficient T-cell production technology: The PBMC-T platform utilizes advanced cell culture and expansion technologies to ensure that T-cells derived from human Peripheral Blood Mononuclear Cells (PBMCs) have a high degree of activity and functional integrity.
2. Wide range of applications: The products of the PBMC-T platform have a wide range of applications in a variety of research fields, including immunotherapy, cancer research, and infectious diseases. Researchers can utilize these highly efficient T cells for in vitro experiments, drug screening, disease modeling, etc.
3. Customized services: InnoModels Biotechnology provides customized services, offering different types and quantities of T cells according to customers' specific needs to meet the requirements of various research projects. This flexibility enables researchers to obtain personalized solutions that meet their experimental needs.

 


4. Strict Quality Control: InnoModels Biotechnology carries out strict quality control of its PBMC-T platform products to ensure that each batch of T cells meets high quality standards. This quality control ensures the reproducibility and reliability of the experiments.
5. Reliable Supply Chain: The production of PBMC-T platform products adopts efficient supply chain management to ensure that customers can obtain the required T cells in a timely manner, and the progress of research will not be affected by supply problems.
By providing high-quality, high-activity T-cell products, InnoModels's PBMC-T platform is committed to advancing scientific research in the fields of immunotherapy and cancer research, and contributing to the discovery of new therapeutic methods and innovations in the field of biomedicine. The wide application of its products will contribute to an in-depth understanding of the mechanism of action of the immune system and provide important support for disease treatment and prevention.

Keyword:

In the field of life sciences, every leap in technology leads to deeper research and medical advances. InnoModels Biotechnology (Beijing) Co., Ltd, with its innovative 3D organoid platform, is providing scientists with an unprecedented research tool, which greatly promotes drug research and development and the exploration of disease mechanisms
In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is like a bright star, illuminating the journey of oncology and tumor immunology drug development with its unique PDX in vivo efficacy model. Today, let's go into InnoModels Biotechnology to learn more about its industry-leading PDX in vivo efficacy model and explore its unlimited potential in drug discovery and development.
In the vast field of cancer research and drug development, InnoModels Biotechnology (Beijing) Co., Ltd. provides powerful support to scientists and doctors with its leading CDX (Cell line-derived xenograft tumor) model platform. The platform not only has diverse tumor cell lines, but also is equipped with a team of experienced experts and advanced experimental technologies, which are dedicated to promoting innovation in biomedical research and clinical treatment.
In the field of life sciences, in vitro killing experimental platform is gradually becoming an important tool for drug development and cell research. Among them, the in vitro killing experimental platform of InnoModels Biotechnology has attracted the attention of many researchers with its unique technical advantages and wide application prospects. In this paper, we will introduce in detail the features and advantages of InnoModels' in vitro killing platform and its applications in scientific research.
In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is leading the forefront of tumor and tumor immunotherapy research with its unique in vivo tumor experimental platform, which is like a bright star. The platform not only integrates the most advanced technologies and experimental methods, but also devotes itself to providing a new generation of experimental animal models close to the clinic
In the vast field of life science and drug discovery, in vitro experimental platforms play a crucial role. As a leader in this field, InnoModels Biotechnology (Beijing) Co., Ltd. provides scientists with a highly controlled and precise experimental environment with its in vitro killing platform, which greatly facilitates the screening of new drugs, the study of drug mechanisms, and the development of immunotherapies.
Previous page
1
2
42

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司